Blog
U.S.-Turkish Relations, Airports, Opioids: RAND Weekly Recap
Jan 17, 2020
This weekly recap focuses on the future of the U.S.-Turkish partnership, helping America's commercial airports meet rising demand, the opioid crisis, and more.
Health Issues
This page offers an easy way for policymakers to access health research and analysis that is relevant to current Congressional agendas. For additional information, to request documents, or to arrange a briefing, contact the RAND Office of Congressional Relations at ocr@rand.org or (703) 413-1100, ext. 5643.
Alerts & Newsletters
RAND periodically sends alerts and newsletters to update Congress on highlights of recent work about health and health care.
Subscribe to Congressional Alerts & Newsletters
Testimony
-
Addressing the U.S. Opioid Crisis: Using an Integrated Systems-Based Approach 2019
Testimony presented before the Senate Judiciary Committee on December 17, 2019.
-
Proposition 63 and the Future of Mental Health Funding in California: Understanding Successes and Challenges: Prevention and Early Intervention 2019
Testimony presented before an informational hearing of the California State Assembly Committee on Budget on December 9, 2019.
-
Scientific Evidence on the Effects of State Gun Laws 2019
Testimony presented before the Pennsylvania State Senate Judiciary Committee on September 25, 2019.
-
Implications of U.S.-China Collaborations on Global Health Issues: Addendum 2019
Document submitted on August 19, 2019, as an addendum to testimony before the U.S.-China Economic and Security Review Commission on July 31, 2019.
-
Illicit Supply of Fentanyl and Other Synthetic Opioids: Transitioning Markets and Evolving Challenges: Addendum 2019
Document submitted on August 19, 2019, as an addendum to testimony before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations on July 25, 2019.
-
Implications of U.S.-China Collaborations on Global Health Issues 2019
Testimony presented before the U.S.-China Economic and Security Review Commission on July 31, 2019.
-
Illicit Supply of Fentanyl and Other Synthetic Opioids: Transitioning Markets and Evolving Challenges 2019
Testimony presented before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations, on July 25, 2019.
-
Reducing Suicide Among U.S. Veterans: Implications from RAND Research 2019
Testimony presented before the House Oversight and Reform Subcommittee on National Security on May 8, 2019.
-
Reducing Disagreements on Gun Policy Through Scientific Research and an Improved Data Infrastructure 2019
Testimony presented before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on March 7, 2019.
-
Evolution of the U.S. Overdose Crisis: Understanding China's Role in the Production and Supply of Synthetic Opioids 2018
Testimony presented before the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations on September 6, 2018.
-
Suicide Prevention in California: Three Goals for Developing a Statewide Plan 2018
Testimony presented before the California Mental Health Services Oversight and Accountability Commission on May 24, 2018.
-
Should Canada "Start Low and Go Slow" When It Comes to Cannabis Potency? 2018
Testimony presented before the Standing Committee on Social Affairs, Science, and Technology Senate of Canada on May 7, 2018.
-
Considering Cannabis Legalization in Canada: Prices, Taxes, and International Implications 2017
Testimony presented before the House of Commons of Canada Standing Committee on Health on September 14, 2017.
-
Creating Better Support for our Nation's Hidden Heroes: A Research Blueprint for Military and Veteran Caregivers 2017
Testimony presented before the Senate Special Committee on Aging on June 14, 2017.
-
Funding Considerations in the Fight Against the Opioid Epidemic: What the Science Tells Us 2017
Testimony presented before the House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on April 5, 2017.
-
Regulating Medical Marijuana Markets: Insights from Scientific Evaluations of State Experiments 2017
Testimony presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on January 25, 2017.
-
Dementia Long-Term Care Policy Options for Family Caregivers and Medicare 2016
Testimony submitted to the Senate Finance Committee, Subcommittee on Health Care on July 13, 2016.
-
Expanding the Use of Telehealth: Promise and Potential Pitfalls: Addendum 2014
Document submitted on June 5, 2014 as an addendum to testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on May 1, 2014.
-
Expanding the Use of Telehealth: Promise and Potential Pitfalls 2014
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on May 1, 2014.
-
Evidence on Home Visiting and Suggestions for Implementing Evidence-Based Home Visiting Through MIECHV: Addendum 2014
Document submitted on April 16, 2014 as an addendum to testimony presented before the House Ways and Means Committee, Subcommittee on Human Resources on April 2, 2014.
-
Evidence on Home Visiting and Suggestions for Implementing Evidence-Based Home Visiting Through MIECHV 2014
Testimony presented before the House Ways and Means Committee, Subcommittee on Human Resources on April 2, 2014.
-
The Monetary Costs of Dementia in the United States 2014
Testimony presented before the Senate Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on February 26, 2014.
-
Suicide Prevention in California: Strategies from Science 2013
Testimony presented before the California State Senate Select Committee on Mental Health on September 24, 2013.
-
The Monetary Costs of Dementia in the United States: Addendum 2013
Document submitted on July 12, 2013 as an addendum to testimony presented before the Senate Special Committee on Aging on April 24, 2013.
-
Physician Payment Reform: Designing a Performance-based Incentive Program: Addendum 2013
Document submitted on July 12, 2013 as an addendum to testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on June 5, 2013.
-
What Should We Learn From Boston? 2013
Testimony presented before the Senate Homeland Security and Governmental Affairs Committee on July 10, 2013.
-
Expanding Medicaid Is the Best Financial Option for States 2013
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health June 12, 2013.
-
Physician Payment Reform: Designing a Performance-based Incentive Program 2013
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on June 5, 2013.
-
The Monetary Costs of Dementia in the United States 2013
Testimony presented before the Senate Special Committee on Aging on April 24, 2013.
-
Efforts to Reform Physician Payment: Tying Payment to Performance 2013
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on February 14, 2013.
-
Allowances for Spinal Hardware under California’s Official Medical Fee Schedule: Issues and Options 2012
Testimony presented before the California State Senate Labor and Industrial Relations Committee on May 9, 2012.
-
Securing the Future of the Social Security Disability Insurance Program 2012
Testimony presented before the House Committee on Ways and Means, Subcommittee on Social Security on March 20, 2012.
-
Suicide Prevention Efforts and Behavioral Health Treatment in the Veterans Health Administration 2011
Testimony presented before the House Veterans' Affairs Committee, Subcommittee on Health on December 2, 2011.
-
Insights from Early RAND Research on Deployment: Effects on U.S. Service Members and Their Families 2011
Testimony presented before the Senate Veterans' Affairs Committee on July 27, 2011.
-
Availability of Drinking Water in California Public Schools 2008
Testimony presented before the California State Assembly Subcommittee on Education on April 2, 2008.
-
Nanomaterials in the Workplace: A Summary of the RAND Policy and Planning Workshop on Occupational Safety and Health 2007
Testimony presented to Public Meeting on Research Needs Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale Materials on January 4, 2007.
-
Developing Process Indicators to Improve Educational Governance: Lessons for Education from Health Care 2005
Testimony presented to the California Little Hoover Commission on June 23, 2005.
-
School-Based Drug Prevention and Other Strategies For Reducing Drug Use 2005
Testimony presented to the Oregon State Senate and House Judiciary Committees on March 17, 2005.
-
After 9/11: Stress and Coping Across America 2001
Testimony submitted to the United States Senate Committee on Health, Education, Labor and Pensions field hearing on "9/11 and NYC Children" June 10, 2002.
-
The Pace of CalWORKs Implementation (February 2000) 1999
Testimony presented at a hearing of the California State Assembly Budget Subcommittee No. 1 on Health and Human Services (Assembly member Gilbert Cedillo, Chair) meeting in Sacramento, California, on February 15, 2000.
-
The Pace of CalWORKs Implementation (December 1999) 1998
Testimony presented at a hearing of the California State Senate Committee on Health and Human Services meeting in Montebello, California, on December 8, 1999.
Briefs
-
The American Working Conditions Survey Finds That Nearly Half of Retirees Would Return to Work 2019
According to the American Working Conditions Survey, more older workers report having meaningful work compared with their prime-age counterparts, and nearly half of retirees would return to work under the right conditions.
-
Countering Sectarianism in the Middle East: Lessons from Lebanon, Bahrain, Syria, and Iraq 2019
This research draws lessons on how to promote resilience to sectarianism and cross-sectarian cooperation through an exploration of four Middle Eastern case studies: Lebanon, Bahrain, Syria, and Iraq.
-
The Ecology of Neonatal Abstinence Syndrome 2019
Newborns exposed to opioids before birth can experience withdrawal symptoms known as neonatal abstinence syndrome (NAS). From 2009 to 2015, the average NAS rate per 1,000 hospital births across eight states rose from about six to more than 25.
-
Evolving the Practice of Evaluating Research-Portfolios 2019
Researchers appraised metrics that medical research entities use to evaluate research portfolios. The work can help organizations select, develop, and revise metrics for their portfolios. This brief summarizes the findings and recommendations.
-
Federal Block Grants to States for Mental Health, Substance Abuse, and Homelessness: Potential Improvements to Funding Formulas 2019
RAND researchers analyzed the formulas for distributing funds to states under three block grants for services related to mental health, substance abuse, and homelessness (unchanged since 1992) to determine whether they should be modified.